Oculis Holding AG
OCS · NASDAQ
$7.49+$0.17 (+2.32%)TodayMarket closed ·
Prev close $7.32
Who owns OCS
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 34.2% of OCS’s shares.
- EQT Partners AB11.2%
- BVCF Management, Ltd.3.9%
- Gildi - lífeyrissjóður3.9%
- abrdn Inc.3.5%
- Next 6 largest institutions11.7%
- All other shareholders65.8%
| Holder | Shares | % of shares |
|---|---|---|
| EQT Partners AB | 6.95M | 11.20% |
| BVCF Management, Ltd. | 2.44M | 3.93% |
| Gildi - lífeyrissjóður | 2.43M | 3.92% |
| abrdn Inc. | 2.16M | 3.48% |
| Millennium Management LLC | 2.04M | 3.29% |
| Pivotal Bioventure Partners Investment Advisor LLC | 1.51M | 2.43% |
| Sherif (Riad M.D.) | 1.07M | 1.72% |
| Citadel Advisors LLC | 987.20K | 1.59% |
| Braidwell LP | 834.18K | 1.34% |
| Perceptive Advisors LLC | 808.83K | 1.30% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Franklin Templeton Investment Funds -Biotechnology Discovery | 582.38K | 0.94% |
| abrdn Healthcare Investors Fund (US) | 579.54K | 0.93% |
| abrdn Healthcare Opportunities Fund | 569.80K | 0.92% |
| Eventide Healthcare & Life Sciences Fund | 430.00K | 0.69% |
| Candriam Equities L Biotechnology | 420.54K | 0.68% |
Short interest
Settled Sep 30, 2026
- Shares short
- 1.77M
- Days to cover
- 6.48
- % of shares outstanding
- 2.85%
- Average daily volume
- 273.29K
- Change since last report
- +14.1%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.